Aloysia gratissima is used in popular medicine as an analgesic and sedative. However, studies on its biological activities are still scarce. Therefore, this work aimed to evaluate the antinociceptive and anti-inflammatory effect of A. gratissima leaves essential oil (OAG) in mice. The OAG was obtained by hydrodistillation and its composition was determined by gas chromatography-mass spectrometry. The sesquiterpenes pinocamphone, β-pinene, and guaiol were the major constituents of OAG. The effect of OAG (1, 10, and 30 mg/kg, p.o.) was assessed by pre-treating male mice 1h before the formalin assay, carrageenan-induced peritonitis test, or the paw edema induced by arachidonic acid (AA). The acute toxicity of OAG (2000 mg/kg, p.o.) was also investigated. The minimum effective dose of OAG in the formalin test was 1 mg/kg. This dose did not affect the locomotor activity of mice. The OAG decreased the number of leukocytes/mm³ in the peritoneal exudate of mice and reduced paw edema 45 min after the arachidonic acid injection. OAG treatment elicited a reduction in NPSH levels in the paw tissue and increased NPSH levels in mice blood plasma and did not cause mice mortality. The OAG is devoid of acute toxicity and shows anti-inflammatory activity, which can be related to the presence of pinocamphone, guaiol, and β-pinene and is mediated, at least in part, by mechanisms that involve the participation of NPSH.
Background/Objectives: Paclitaxel is a chemotherapy drug used to treat various tumours, but its use is often limited by an acute and chronic pain syndrome that is poorly managed. Naringin and its aglycone, naringenin, exhibit antioxidant, antitumour, anti-inflammatory, and antinociceptive effects, making them potential alternative treatments. However, their low water solubility limits their oral bioavailability in humans. Micronisation in a supercritical medium reduces particle size and enhances the dissolution of compounds, offering a possible solution. In this study, we investigated whether micronising naringin and naringenin via supercritical technology could improve their dissolution and oral efficacy against paclitaxel-induced pain syndrome. Methods: Micronisation was performed using supercritical CO2. Molecular docking was used to analyse the binding of naringin and naringenin to TRPV1, a key target for pain relief. Swiss mice were used in capsaicin (TRPV1 agonist)-induced nociception and paclitaxel-caused acute and chronic pain models. We assessed mechanical, cold, and heat sensitivity, potential adverse effects, and TRPV1 mRNA expression. Results: Micronisation improved the apparent dissolution profile of molecules. Docking results showed that naringin and naringenin bind to TRPV1. Both micronised compounds reduced capsaicin-induced nociception without affecting locomotion or body temperature. Micronised naringin and naringenin alleviated mechanical and cold allodynia, as well as thermal hyperalgesia in both acute and chronic paclitaxel-induced pain, outperforming their conventional forms. They also downregulated TRPV1 mRNA expression in the mice’s sciatic nerve. Conclusions: Taken together, these results show that supercritical micronisation improved the apparent dissolution and oral antinociceptive efficacy of naringin and naringenin, emphasising their potential as promising alternatives for managing paclitaxel-induced pain, with TRPV1 being a probable contributor to the observed antinociceptive effects.
Apigenin is a flavone found in fruits, chamomile, parsley, and celery, with several reported biological properties, including antioxidant, anti-inflammatory, and neuroprotective effects against memory-related cognitive impairment. Apigenin's bioactivity is limited by its low solubility and high permeability, and it is classified as a Biopharmaceutics Classification System II substance. This profile leads to pharmacokinetic limitations that may compromise its pharmacological application. Thus, this study aimed to improve the dissolution rate of apigenin by reducing particle size, with the potential to improve bioavailability and biological effects. The Gas-Antisolvent (GAS) technique using supercritical CO2 was used to micronize apigenin, reducing the average particle size from 26.09 μm (raw apigenin) to 3.22 μm (micronized apigenin). After GAS micronization, XRPD showed reduced crystallinity, corroborated by DSC results. FTIR analysis confirmed that there were no alterations to the chemical structure, indicating that no chemical degradation occurred during processing. Residual solvent analysis at 127.36 ppm indicated that micronized apigenin meets the International Council for Harmonisation standards. The dissolution rate of micronized apigenin increased in acidic (pH 1.2) and buffered (pH 6.8) solutions compared with the raw form. In vivo assays showed no effect on memory deficits in zebrafish with both raw and micronized apigenin. However, the micronized form increased exploratory behaviour and antioxidant defences (as indicated by NPSH levels). Overall, GAS micronization effectively reduced apigenin particle size and improved its dissolution rate without detectable chemical degradation. These findings support GAS micronization as a promising strategy for improving the physicochemical properties of poorly water-soluble compounds such as apigenin.